Park National Adds Karen Morrison and Kelly Gratz to Board

Park National Corporation (NYSE American: PRK) has announced the election of Karen Morrison and Kelly Gratz to its board of directors, expanding the board to 16 members, effective July 1, 2024. This addition brings valuable expertise to the board, as both individuals have extensive experience in leading companies across different industries.

Karen Morrison, currently serving as president of the OhioHealth Foundation and senior vice president of OhioHealth Corporation, has over 30 years of experience with OhioHealth and leads the enterprise strategy for external affairs. She holds a graduate degree in preventive medicine from The Ohio State University College of Medicine and Public Health and a juris doctor from Capital University. Morrison's term as a director will expire on the date of Park’s annual meeting of shareholders in 2026.

Kelly Gratz, the chief executive officer of G2O, a customer experience transformation company, brings more than 35 years of experience as an executive leader in the technology, healthcare, and pharmaceutical industries. Gratz holds a bachelor’s degree from the University of Dayton and her term as a director will expire on the date of Park’s annual meeting of shareholders in 2027.

Both Morrison and Gratz will serve as members of the board’s Risk Committee, offering their expertise in risk management and governance.

Park National Corporation, headquartered in Newark, Ohio, has $9.9 billion in total assets as of March 31, 2024. Its banking operations are conducted through its subsidiary, The Park National Bank, and it also operates subsidiaries such as Scope Leasing, Inc. (d.b.a. Scope Aircraft Finance), Guardian Financial Services Company (d.b.a. Guardian Finance Company), and SE Property Holdings, LLC.

The additions of Morrison and Gratz to the board bring fresh perspectives and a wealth of knowledge to Park National Corporation as it continues to grow and find new ways to serve its stakeholders. As a result of these announcements, the company's shares have moved 0.8% on the market, and are now trading at a price of $140.05. For the full picture, make sure to review Park National's 8-K report.

The above analysis is intended for educational purposes only and was performed on the basis of publicly available data. It is not to be construed as a recommendation to buy or sell any security. Any buy, sell, or other recommendations mentioned in the article are direct quotations of consensus recommendations from the analysts covering the stock, and do not represent the opinions of Market Inference or its writers. Past performance, accounting data, and inferences about market position and corporate valuation are not reliable indicators of future price movements. Market Inference does not provide financial advice. Investors should conduct their own review and analysis of any company of interest before making an investment decision.